The FDA has Announced Their Approval of Evkeeza for Homozygous Familial Hypercholesterolemia
source: pixabay.com

The FDA has Announced Their Approval of Evkeeza for Homozygous Familial Hypercholesterolemia

The FDA has just announced their approval of Evkeeza as a therapy for those living with homozygous familial hypercholesterolemia. The therapy is owned by Regeneron Pharmaceuticals. It was evaluated with…

Continue Reading The FDA has Announced Their Approval of Evkeeza for Homozygous Familial Hypercholesterolemia